Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
![]()
Reuters NewMedia - May 23, 2007
Wendell Roelf
At an AIDS candle-lighting memorial in Cape Town, Health Minister Manto Tshabalala-Msimang said making HIV treatment and support programmes more available to those infected with the virus was the linchpin of the government's prevention strategy.
"Affected communities have to be aware and must be encouraged to access treatment, care and support services that government has made available free of charge throughout the country," said Tshabalala-Msimang, who has courted controversy with her unorthodox views on AIDS.
Tshabalala-Msimang has been a pivotal figure in South Africa's HIV/AIDS crisis since becoming health minister in 1999, engaging in bitter debates with AIDS activists and at times appearing to question accepted HIV science.
South Africa will next month unveil a strategic plan to combat what is one of the world's worst HIV/AIDS epidemics. About one in nine South Africans, or an estimated 5 million, are HIV-positive, and up to 1,000 people die from AIDS each day.
The minister, who has been resting at home since she was operated on in March after a long-running battle with hepatitis, did not mention whether the government would speed up its rollout of anti-retroviral drugs (ARVs) to combat the disease.
The government has said it hopes to expand the number of people accessing ARVs five-fold to 1 million by 2011.
Tshabalala-Msimang drew international condemnation at last year's world AIDS conference in Toronto for promoting garlic and beetroot as treatments for HIV.
Her withdrawal from public life and the prospect that she might not return to lead the health department privately delighted some activists and scientists, who have long considered her an obstacle.
Tshabalala-Msimang, however, suggested on Wednesday that she would be returning to her old job.
"My doctor has asked (me) to ease back into work ... I'm feeling strong. My last evaluation indicates that I am fine."
070523
RE070533
Copyright © 2007 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .